-
Almazan F, Dediego ML, Galan C, Escors D, Alvarez E, Ortego J, Sola I, Zuniga S, Alonso S, Moreno JL, Nogales A, Capiscol C, Enjuanes L, 2006: Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis[J]. J Virol, 80, 10900-10906. doi: 10.1128/JVI.00385-06
-
Carrillo A, Stewart KD, Sham HL, Norbeck DW, Kohlbrenner WE, Leonard JM, Kempf DJ, Molla A, 1998: In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor[J]. J Virol, 72, 7532-7541. doi: 10.1128/JVI.72.9.7532-7541.1998
-
Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D, 2009: Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase[J]. Proc Natl Acad Sci U S A, 106, 3484-3489. doi: 10.1073/pnas.0808790106
-
Chen Y, Liu Q, Guo D, 2020: Emerging coronaviruses: genome structure, replication, and pathogenesis[J]. J Med Virol, 92, 2249-2249. doi: 10.1002/jmv.26234
-
Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M, 2020: Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19[J]. Gastroenterology, 158, 2298-2301.e2297. doi: 10.1053/j.gastro.2020.03.045
-
Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, Wang T, Sun Q, Ming Z, Zhang L, Ge J, Zheng L, Zhang Y, Wang H, Zhu Y, Zhu C, Hu T, Hua T, Zhang B, Yang X, Li J, Yang H, Liu Z, Xu W, Guddat LW, Wang Q, Lou Z, Rao Z, 2020: Structure of the RNA-dependent RNA polymerase from COVID-19 virus[J]. Science, 368, 779-782. doi: 10.1126/science.abb7498
-
Hannemann H, 2020: Viral replicons as valuable tools for drug discovery[J]. Drug Discov Today, 25, 1026-1033. doi: 10.1016/j.drudis.2020.03.010
-
Hierholzer JC, Palmer EL, Whitfield SG, Kaye HS, Dowdle WR, 1972: Protein composition of coronavirus OC 43[J]. Virology, 48, 516-527. doi: 10.1016/0042-6822(72)90062-1
-
Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M, 1995: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection[J]. Nature, 373, 123-126. doi: 10.1038/373123a0
-
Hoffmann M, Mosbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Kruger N, Gassen NC, Muller MA, Drosten C, Pohlmann S, 2020: Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2[J]. Nature, 585, 588-590. doi: 10.1038/s41586-020-2575-3
-
Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Schafer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O'Neal WK, Randell SH, Boucher RC, Baric RS, 2020: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract[J]. Cell, 182, 429-446.e414. doi: 10.1016/j.cell.2020.05.042
-
Hussain S, Pan J, Chen Y, Yang Y, Xu J, Peng Y, Wu Y, Li Z, Zhu Y, Tien P, Guo D, 2005: Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus[J]. J Virol, 79, 5288-5295. doi: 10.1128/JVI.79.9.5288-5295.2005
-
Jin Z, Zhao Y, Sun Y, Zhang B, Wang H, Wu Y, Zhu Y, Zhu C, Hu T, Du X, Duan Y, Yu J, Yang X, Yang X, Yang K, Liu X, Guddat LW, Xiao G, Zhang L, Yang H, Rao Z, 2020: Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur[J]. Nat Struct Mol Biol, 27, 529-532. doi: 10.1038/s41594-020-0440-6
-
Kang CK, Seong MW, Choi SJ, Kim TS, Choe PG, Song SH, Kim NJ, Park WB, Oh MD, 2020: In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses[J]. Korean J Intern Med, 35, 782-787. doi: 10.3904/kjim.2020.157
-
Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, Symonds WT, McHutchison JG, Membreno FE, 2014: Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial[J]. Lancet, 383, 515-523. doi: 10.1016/S0140-6736(13)62121-2
-
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M, 2003: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J]. Nature, 426, 450-454. doi: 10.1038/nature02145
-
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R, 1999: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line[J]. Science, 285, 110-113. doi: 10.1126/science.285.5424.110
-
Pan J, Peng X, Gao Y, Li Z, Lu X, Chen Y, Ishaq M, Liu D, Dediego ML, Enjuanes L, Guo D, 2008: Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication[J]. PLoS ONE, 3, e3299-. doi: 10.1371/journal.pone.0003299
-
Pan JA, Ullman E, Dou Z, Zong WX, 2011: Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes[J]. Mol Cell Biol, 31, 3158-3170. doi: 10.1128/MCB.05460-11
-
Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M, 2020: Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)[J]. J Med Virol, 92, 699-702. doi: 10.1002/jmv.25915
-
Pizzorno A, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O, 2020: In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2[J]. Antivir Res, 181, 104878-. doi: 10.1016/j.antiviral.2020.104878
-
Shrestha DB, Budhathoki P, Syed NI, Rawal E, Raut S, Khadka S, 2020: Remdesivir: a potential game-changer or just a myth? A systematic review and meta-analysis[J]. Life Sci, 264, 118663-.
-
Thi Nhu Thao T, Labroussaa F, Ebert N, V'Kovski P, Stalder H, Portmann J, Kelly J, Steiner S, Holwerda M, Kratzel A, Gultom M, Schmied K, Laloli L, Husser L, Wider M, Pfaender S, Hirt D, Cippa V, Crespo-Pomar S, Schroder S, Muth D, Niemeyer D, Corman VM, Muller MA, Drosten C, Dijkman R, Jores J, Thiel V, 2020: Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform[J]. Nature, 582, 561-565. doi: 10.1038/s41586-020-2294-9
-
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G, 2020: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 30, 269-271. doi: 10.1038/s41422-020-0282-0
-
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ, 2020: A new coronavirus associated with human respiratory disease in China[J]. Nature, 579, 265-269. doi: 10.1038/s41586-020-2008-3
-
Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, Shi PY, 2020a: An infectious cDNA clone of SARS-CoV-2[J]. Cell Host Microbe, 27, 841-848.e843. doi: 10.1016/j.chom.2020.04.004
-
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY, 2020b: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19[J]. Nat Commun, 11, 5214-. doi: 10.1038/s41467-020-19055-7
-
Yount B, Curtis KM, Baric RS, 2000: Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model[J]. J Virol, 74, 10600-10611. doi: 10.1128/JVI.74.22.10600-10611.2000
-
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL, 2020: A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 579, 270-273. doi: 10.1038/s41586-020-2012-7